New York, NY, United States of America

Natalie Pica

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2018.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Spotlight: Natalie Pica**

Introduction

Natalie Pica is a talented inventor based in New York, NY, known for her significant contributions to the field of virology. With a focus on innovative vaccine development, her work is particularly relevant in the fight against influenza.

Latest Patents

Natalie holds a noteworthy patent titled "Influenza virus vaccines and uses thereof." This patent includes flu hemagglutinin polypeptides, including chimeric influenza virus hemagglutinin polypeptides, and polypeptides with modified glycosylation sites. It also covers compositions and vaccines that comprise these polypeptides, along with methods for their use, showcasing her expertise in immunology and vaccine technology.

Career Highlights

Currently, Natalie Pica is affiliated with the Icahn School of Medicine at Mount Sinai, where she likely collaborates with other leading researchers to enhance understanding and treatment of viral infections. Her innovative work and dedication to biomedical research exemplify the essential role of inventors in advancing public health.

Collaborations

Throughout her career, Natalie has worked alongside notable researchers such as Adolfo Garcia-Sastre and Peter M. Palese. These collaborations not only highlight her commitment to teamwork in scientific discovery but also contribute to the advancement of vaccine technologies that save lives globally.

Conclusion

Natalie Pica's contributions to the field of influenza vaccine development are invaluable, marking her as a prominent inventor in the realm of biotechnology. Through her work at the Icahn School of Medicine at Mount Sinai, she continues to impact the scientific community and public health positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…